New Medtronic Pacemaker, Defibrillators Available in Europe

Medtronic announced the European introductions of the Medtronic EnRhythm pacemaker (dual-chamber) and the Medtronic EnTrust implantable cardioverter-defibrillators (ICDs) (single- and dual-chamber versions).

The EnRhythm pacemaker is an ideal pacemaker for patients who have an abnormally slow or weak heart rhythm due to sinus node dysfunction or intermittent AV block. The EnTrust ICD is indicated for patients who are at risk of developing abnormally fast and potentially life-threatening heartbeats that can lead to sudden cardiac arrest. The dual-chamber EnTrust device also is indicated to treat atrial tachyarrhythmias.

These products incorporate several unique features that provide important patient benefits, including an innovative pacing mode called managed ventricular pacing (MVP) available in the dual-chamber EnRhythm and EnTrust devices. The EnRhythm device is the first-ever pacemaker to include MVP, which Medtronic first introduced in its Intrinsic ICD in 2004, the company said. The company received CE Mark for these devices on Feb. 4.